APTAMER GROUP PLC ORD 0.1P(APTA)股吧_APTAMER GROUP PLC ORD 0.1P怎么样

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
23	0	Programme and technical development update	APTAMER GROUP PL资讯	06-25 02:21
21	0	Rapid testing programme for fortified foods	APTAMER GROUP PL资讯	06-08 02:17
44	0	Result of General Meeting	APTAMER GROUP PL资讯	04-13 08:13
34	0	Result of Retail Offer and Posting of Notice of GM	APTAMER GROUP PL资讯	03-31 02:25
38	0	Retail Offer to raise up to ￡0.5 million	APTAMER GROUP PL资讯	03-26 04:09
41	0	Results of Placing	APTAMER GROUP PL资讯	03-26 03:34
40	0	Interim Results and Notice of Investor Webinar	APTAMER GROUP PL资讯	03-25 04:01
38	0	Proposed Placing, Subscription and Retail Offer	APTAMER GROUP PL资讯	03-25 03:29
42	0	Launch of targeted radiopharmaceutical programme	APTAMER GROUP PL资讯	03-18 03:34
2244	0	Block Listing Interim Review	APTAMER GROUP PL资讯	03-10 11:32
54	0	Technical Feasibility for Pathogen Detector	APTAMER GROUP PL资讯	02-17 03:32
50	0	Optimer？ Technology in Launched Library Prep Kit	APTAMER GROUP PL资讯	02-11 03:23
39	0	Contract wins and first cash licensing receipts	APTAMER GROUP PL资讯	01-29 03:26
59	0	Trading update - Media comment and speculation	APTAMER GROUP PL资讯	01-08 12:07
44	0	Half Year Trading Update	APTAMER GROUP PL资讯	01-07 03:18
44	0	Aptamer signs licensing agreement with Alphazyme	APTAMER GROUP PL资讯	12-23 03:13
43	0	Licensing agreement with Twist Bioscience	APTAMER GROUP PL资讯	12-16 06:37
49	0	Results of 2025 Annual General Meeting	APTAMER GROUP PL资讯	11-27 09:04
49	0	AGM Statement	APTAMER GROUP PL资讯	11-27 03:26
34	0	Strong contract wins build commercial momentum	APTAMER GROUP PL资讯	11-14 03:20
45	0	New contract with top five pharma company	APTAMER GROUP PL资讯	11-04 03:21
57	0	Posting of Annual Report and Notice of AGM	APTAMER GROUP PL资讯	11-03 03:34
48	0	Full Year Results for the 12mths to 30 June 2025	APTAMER GROUP PL资讯	10-14 02:19
40	0	New contract with top 10 pharma	APTAMER GROUP PL资讯	10-13 02:20
46	0	Notice of Results, Analyst & Investor Presentation	APTAMER GROUP PL资讯	10-10 02:20
52	0	Major top 3 global pharma contract win	APTAMER GROUP PL资讯	10-08 02:15
39	0	Investor Event and Presentation	APTAMER GROUP PL资讯	09-26 02:17
51	0	New contract with Metir plc	APTAMER GROUP PL资讯	09-11 02:22
51	0	Notification of dealings by a director/PDMR	APTAMER GROUP PL资讯	09-09 02:17
47	0	Therapeutic development agreement with Invizius	APTAMER GROUP PL资讯	09-02 02:17
43	0	Block Listing Interim Review	APTAMER GROUP PL资讯	08-28 02:29
51	0	Biomarker Discovery Service Launch	APTAMER GROUP PL资讯	08-27 02:23
49	0	Update on licensing and development progress	APTAMER GROUP PL资讯	08-22 02:17
49	0	Exercise of warrants	APTAMER GROUP PL资讯	08-19 02:27
55	0	Holding(s) in Company	APTAMER GROUP PL资讯	08-18 10:48
61	0	Contract extension with global pharma partner	APTAMER GROUP PL资讯	08-18 02:23
63	0	Investor Technical Webinar	APTAMER GROUP PL资讯	08-08 02:19
75	0	Holding(s) in Company	APTAMER GROUP PL资讯	08-08 12:27
58	0	Holding(s) in Company	APTAMER GROUP PL资讯	08-05 03:16
65	0	Investor Webinar	APTAMER GROUP PL资讯	07-31 08:31
58	0	Trading Update	APTAMER GROUP PL资讯	07-31 02:28
72	0	Holding(s) in Company	APTAMER GROUP PL资讯	07-28 07:27
71	0	Result of General Meeting	APTAMER GROUP PL资讯	07-24 06:51
58	0	Additional work commissioned by Unilever	APTAMER GROUP PL资讯	07-21 02:19
59	0	Issue of Equity in lieu of Non-Exec Director Fees	APTAMER GROUP PL资讯	07-18 02:19
64	0	Holding(s) in Company	APTAMER GROUP PL资讯	07-09 09:56
63	0	Posting of Circular and Notice of General Meeting	APTAMER GROUP PL资讯	07-08 02:20
64	0	Placing to raise ￡2.0 million	APTAMER GROUP PL资讯	07-04 02:19
62	0	Liver fibrosis breakthrough with Optimer？ platform	APTAMER GROUP PL资讯	06-30 02:16
60	0	Agreement with global life sciences leader	APTAMER GROUP PL资讯	06-25 02:15
80	0	Unilever second Optimer development programme	APTAMER GROUP PL资讯	05-30 02:14
59	0	Aptamer Announces New Data at ASGCT	APTAMER GROUP PL资讯	05-15 02:38
61	0	Optimer licensing agreements and repeat contracts	APTAMER GROUP PL资讯	05-15 02:18
67	0	Alzheimer’s test advanced and royalty agreement	APTAMER GROUP PL资讯	05-06 02:44
71	0	Licensing agreed for Optimer as vaccine adjuvant	APTAMER GROUP PL资讯	04-30 03:04
75	0	Aptamer Presenting at ASGCT Annual Meeting	APTAMER GROUP PL资讯	04-29 02:14
55	0	New Corporate Presentation and Investor Factsheet	APTAMER GROUP PL资讯	04-24 02:14
63	0	Interim Results	APTAMER GROUP PL资讯	03-11 03:26
66	0	TR-1: Standard form notification of major holdings	APTAMER GROUP PL资讯	02-27 08:53
78	0	Block Listing Interim Review	APTAMER GROUP PL资讯	02-25 04:30
65	0	Notice of Results and Investor Presentation	APTAMER GROUP PL资讯	02-25 03:24
93	0	Issue of Equity in lieu of Director fees	APTAMER GROUP PL资讯	01-28 10:58
86	0	Half Year Trading Update	APTAMER GROUP PL资讯	01-28 03:09
76	0	Notification of dealings by a director/PDMR	APTAMER GROUP PL资讯	01-13 07:43
110	0	Holding(s) in Company	APTAMER GROUP PL资讯	12-30 03:08
105	0	Notification of dealings by a director/PDMR	APTAMER GROUP PL资讯	12-20 12:47
122	0	New Development Contract	APTAMER GROUP PL资讯	12-19 03:16
91	0	TR-1: Standard form notification of major holdings	APTAMER GROUP PL资讯	12-18 06:56
99	0	Notification of dealings by a director/PDMR	APTAMER GROUP PL资讯	12-16 07:31
114	0	Holding(s) in Company	APTAMER GROUP PL资讯	12-12 03:58
100	0	Notification of dealings by a director/PDMR	APTAMER GROUP PL资讯	12-09 11:34
87	0	Notification of dealings by a director/PDMR	APTAMER GROUP PL资讯	12-09 09:52
98	0	Grant of Options and Director Fee Shares	APTAMER GROUP PL资讯	12-09 03:17
111	0	New Scientific Advisory Board Members	APTAMER GROUP PL资讯	12-06 03:12
114	0	Technical Update	APTAMER GROUP PL资讯	12-05 03:15
95	0	Investor Webinar	APTAMER GROUP PL资讯	12-04 03:16
95	0	Results of 2024 Annual General Meeting	APTAMER GROUP PL资讯	11-29 07:08
90	0	AGM Statement	APTAMER GROUP PL资讯	11-29 03:14
95	0	Agreement extended with genetic medicines customer	APTAMER GROUP PL资讯	11-07 03:47
90	0	Commercial Trading Update	APTAMER GROUP PL资讯	11-06 03:15

emytylist